MeiraGTx Holdings plc - Ordinary Shares (MGTX) Covered Calls

You can sell covered calls on MeiraGTx Holdings plc - Ordinary Shares to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for MGTX (prices last updated Fri 4:16 PM ET):

MeiraGTx Holdings plc - Ordinary Shares (MGTX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
5.93 +0.01 5.89 5.97 139K - 0.5
Covered Calls For MeiraGTx Holdings plc - Ordinary Shares (MGTX)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 20 5 0.00 5.97 -16.2% -203.9%
Jan 17 5 0.00 5.97 -16.2% -103.7%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

MeiraGTx Holdings plc, a clinical-stage gene therapy company, focusing on developing treatments for patients living with serious diseases. The company develops various therapies for ocular diseases, including rare inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; neurodegenerative diseases, such as amyothrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. The company was founded in 2015 and is based in New York, New York.